Episode
Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics
- Podcast
- Stocks To Watch
- Published
- May 27, 2026
- Duration seconds
- 1518
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/stocks-to-watch-5696376/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This interview is disseminated on behalf of Conexeu Sciences Inc. Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration. Learn more: https://www.conexeu.com/ Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hU And follow us to stay updated: https://www.youtube.com/GlobalOneMedia